Acute Toxicity at 3 Months for 54 Included Patients
| Hypoxia (n = 34), trial arm | No hypoxia | ||||||||
| Boost (n = 24) | 66 Gy (n = 10) | 66 Gy (n = 20) | |||||||
| Acute adverse events | G1&2 | G3 | G4&5 | G1&2 | G3 | G4&5 | G1&2 | G3 | G4&5 |
| Asthenia | 5 | 6 | 1 | 1 | |||||
| Pain | 2 | 1 | 4 | ||||||
| Thoracic pain | 5 | 2 | |||||||
| Dysphagia | 17 | 1 | 6 | 3 | 1 | 11 | 4 | ||
| Dyspnea | 1 | 3 | 1 | 6 | |||||
| Hemoptysis | 1 | 1 (G5) | 1 | ||||||
| Dry skin or pruritus | 15 | 1 | 1 | 9 | |||||
| Anorexia | 3 | 2 | 3 | ||||||
| Pneumonitis | 2 | 1 (G4) | 3 | ||||||
| Cough or expectoration | 16 | 6 | 11 | ||||||
| Hematologic toxicities | 2 | 1 | 1 | 1 | 4 | 2 | 1 (G4) | ||
| Chemotherapy toxicities | 25 | 3 | 7 | 5 | 12 | 2 | 1 (G4) | ||
| Other toxicities | 1 | 5 | |||||||